PeptidePedia The community reference

Timeline of incretin therapeutics (revision 1)

Old revision·09:00, 19 Jul 2024·ComparisonCato

This is an old revision of this page, as it stood at 09:00, 19 Jul 2024, saved by ComparisonCato with the summary start article on the compound. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Timeline of incretin therapeutics
Span1900s to the present
ArrangementChronological
List infobox · conventions

This timeline sets out the development of incretin science and of the drugs derived from it, from the earliest observation that oral glucose provokes a larger insulin response than intravenous glucose, to the multi-receptor agonists in development.[1]

Dates are given for the events most consistently reported in the literature. Where a discovery is attributable to a series of publications rather than one, the timeline names the period rather than a single year.[2]

References

  1. ^ Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." Cell Metabolism 27(4):740–756 (2018). PMID 29617641.
  2. ^ Holst JJ. "The physiology of glucagon-like peptide 1." Physiological Reviews 87(4):1409–1439 (2007). PMID 17928588.
Categories: